Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody...

Related Keywords

San Diego ,California ,United States ,Navjot Rai ,Mike Maclean ,Avidity Biosciences Inc ,Linkedin ,Nasdaq ,Twitter ,Avidity Biosciences ,Antibody Oligonucleotide Conjugates ,Human Capital Management Committee ,Inducement Incentive Award Plan ,Nasdaq Listing Rule ,Nasdaq Global Market ,Oligonucleotide Conjugates ,